Global Insight Services have recently published a report on Nonalcoholic Steatohepatitis (NASH) Pipeline landscape. The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration.
Nonalcoholic steatohepatitis (NASH) is a type of fatty liver disease. It is characterized by the accumulation of fat in the liver, inflammation, and damage. NASH can lead to cirrhosis, liver failure, and death. The exact cause of NASH is unknown, but it is believed to be associated with obesity, insulin resistance, and diabetes. Treatment of NASH is focused on weight loss, exercise, and the control of diabetes and insulin resistance.
NASH is most common in patients who are overweight or obese and other risk factors include diabetes, high cholesterol, high triglycerides, poor diet, metabolic syndrome, polycystic ovary syndrome, sleep apnea, underactive thyroid (hypothyroidism).
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31004
Report Highlights
Global Insight Service’s, Nonalcoholic Steatohepatitis (NASH) – Drug Pipeline Landscape, 2022 report provides an overview of the Nonalcoholic Steatohepatitis (NASH) pipeline drugs. This report covers detailed insights on Nonalcoholic Steatohepatitis (NASH) drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Nonalcoholic Steatohepatitis (NASH) pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Ask For Customization : https://www.globalinsightservices.com/request-customization/GIS31004
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.
Some of the key players involved in development of Nonalcoholic Steatohepatitis (NASH) therapeutics are :
- 180 Life Corp
- 89bio, Inc.
- Acquist Theraputics Inc
- Akero Therapeutics, Inc
- Algernon Pharmaceuticals Inc
- Aligos Therapeutics
- Allysta Pharmaceuticals Inc
- Altay Therapeutics Inc
- Altimmune, Inc.
- Amgen
- Amytrx Therapeutics Inc
- AngioLab, Inc.
- AptaBio Therapeutics Inc
- AptamiR Therapeutics Inc
Report Segmentation
Assessment by Stage of Development
Assessment by Companies
Assessment by Target
Assessment by Mechanism of Action
Assessment by Molecule Type
Assessment by Route of Administration
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31004
With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/